One stock in this five-name healthcare basket costs more in annual tax than the other four combined, and the IRS treats its payout differently from the rest. Find out which one belongs in your Roth first.
Caroline, 9, and Zoe, 12, will appear on limited-edition Well Market snack packaging, and each winner's nonprofit soccer organization will receive a $25,000 grant WOONSOCKET, R.I., Nov. 20, 2026 /PRNewswire/ -- CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), and its Well Market® store brand consumables line today named Caroline, age 9, of Holmes Beach, Florida, and Zoe, age 12, of Los Angeles, California, the Grand Prize winners of the first CVS Home Team Heroes soccer contest.
Aetna For You & Baby is a multi-year initiative to achieve a 30-percentage-point increase in access to whole-patient maternal and infant care over the next five years. Today, the Centers for Disease Control and Prevention estimates that more than 80% of pregnancy-related deaths are preventable.
CVS has the cash, the earnings momentum, and a recovering Aetna, yet shareholders have collected the same payout for 12 straight quarters. Management has other priorities first, and a planned breakup could complicate the answer.
Healthcare demand holds up when the economy slows, which makes the sector a natural place for retirees to look for income heading into the new year. The quality of that income varies widely, though.
CVS Health® (NYSE:CVS) is being recognized with seven Stevie® Awards for technology and responsible AI innovations that are simplifying access to care, supporting colleagues in their work, and helping communities respond to emergencies. The honors span two of the world's most competitive global award programs, the Stevie Awards for Technology Excellence and the International Business Awards® ("International Stevies").
The analysis looked at patients who were newly taking highly popular GLP-1 medicines — which mimic the GLP-1 hormone and reduce appetite — from Eli Lilly and Novo Nordisk, and compared them to similar patients who were not taking the drugs.
CVS Health plans to separate into two independent publicly traded companies. Management raised 2026 adjusted earnings per share guidance to at least $8.20.
Real-world analysis finds better outcomes and lower medical spending, but current prices limit the full economic value WOONSOCKET, R.I., Nov. 15, 2026 /PRNewswire/ -- CVS Health today released new research grounded in real-world data that puts numbers behind a central question facing employers and health plans as GLP-1 use grows: Do the medicines save enough elsewhere in the health care system to offset their cost?